World Pharma News Digest - 17.06.2014
7 views
Skip to first unread message
Ruslan David
Jun 17, 2014, 6:02:01 AM6/17/14
to worldph...@googlegroups.com
BBK Worldwide makes clinical engagement process easier with mobile apps
BBK Worldwide, a leading clinical trial marketing firm, has unveiled two new mobile apps for patient and site engagement, My Clinical Study Buddy℠ and My Clinical Study Buddy℠ Protocol Pointers Edition. Available for Apple® and Android™ mobile phones and tablets, both apps are available on the App Store℠ and Google Play™ and are being demoed at this week's DIA 2014 50th Annual Meeting at the San Diego Convention Center, San Diego, Calif., June 16-19 at BBK booth #2309.
Read more...
http://www.worldpharmanews.com/development/2806-bbk-worldwide-makes-clinical-engagement-process-easier-with-mobile-apps
Pfizer opens new state-of-the-Art research and development site in Cambridge, Massachusetts
Pfizer Inc. (NYSE:PFE) has announced the opening of a new 280,000 square-foot Research and Development (R&D) hub in Cambridge, Mass. The new Pfizer facilities in Kendall Square bring together 1,000 colleagues from three area locations and position Pfizer in closer proximity to leading academic institutions, hospitals and patient organizations.
Read more...
http://www.worldpharmanews.com/pfizer/2805-pfizer-opens-new-state-of-the-art-research-and-development-site-in-cambridge-massachusetts
Scientists closing in on new obesity drug
Obesity and diabetes are among the fastest growing health problems in the world, and the hunt is in for a pill that can fight the problem. Now a Danish/British team has come up with a smart tool that will speed up the scientific hunting process, and we may be one step closer to a pill against obesity.
Read more...
http://www.worldpharmanews.com/research/2804-scientists-closing-in-on-new-obesity-drug
FDA launches openFDA to provide easy access to valuable FDA public data
The U.S. Food and Drug Administration has launched openFDA, a new initiative designed to make it easier for web developers, researchers, and the public to access large, important public health datasets collected by the agency.
Read more...
http://www.worldpharmanews.com/fda/2803-fda-launches-openfda-to-provide-easy-access-to-valuable-fda-public-data
Viral infections could be inhibited by naturally occurring protein
By boosting a protein that naturally exists in our cells, an international team of researchers led by the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter, has found a potential way to enhance our ability to sense and inhibit viral infections.
Read more...
http://www.worldpharmanews.com/research/2802-viral-infections-could-be-inhibited-by-naturally-occurring-protein
Mindprint implements market-leading automation solution for Ockham Oncology
Mindprint Inc. and Ockham Development, Inc. have implemented an innovative automation software system to help the global CRO manage trials efficiently to ensure a more focused approach to its core oncology mission.
Read more...
http://www.worldpharmanews.com/corporate/2801-mindprint-implements-market-leading-automation-solution-for-ockham-oncology
Researchers uncover common heart drug's link to diabetes
McMaster University researchers may have found a novel way to suppress the devastating side effect of statins, one of the worlds' most widely used drugs to lower cholesterol and prevent heart disease. The research team - led by Jonathan Schertzer, assistant professor of Biochemistry and Biomedical Sciences and Canadian Diabetes Association Scholar - discovered one of the pathways that link statins to diabetes.
Read more...
http://www.worldpharmanews.com/research/2800-researchers-uncover-common-heart-drugs-link-to-diabetes
Resistance to lung cancer targeted therapy can be reversed, study suggests
Up to 40 percent of lung cancer patients do not respond to a targeted therapy designed to block tumor growth - a puzzling clinical setback that researchers have long tried to solve. Now, scientists at Georgetown Lombardi Comprehensive Cancer Center and the National Cancer Institute have discovered why that intrinsic resistance occurs - and they pinpoint a drug they say could potentially reverse it.
Read more...
http://www.worldpharmanews.com/research/2799-resistance-to-lung-cancer-targeted-therapy-can-be-reversed-study-suggests
'Tomato pill' improves function of blood vessels in patients with cardiovascular disease
A daily supplement of an extract found in tomatoes may improve the function of blood vessels in patients with cardiovascular disease, according to new research from the University of Cambridge. The incidence of cardiovascular disease varies worldwide, but is notably reduced in southern Europe, where a 'Mediterranean diet' consisting of a larger consumption of fruit, vegetables and olive oil predominates.
Read more...
http://www.worldpharmanews.com/research/2798-tomato-pill-improves-function-of-blood-vessels-in-patients-with-cardiovascular-disease
PharmaNews.eu / Latest News
Burden of asthma revealed in newly published Mundipharma research
http://www.pharmanews.eu/research-and-development/1453-burden-of-asthma-revealed-in-newly-published-mundipharma-research
mAbxience acquires 100% of biopharmaceutical Genhelix
http://www.pharmanews.eu/research-and-development/1452-mabxience-acquires-100-of-biopharmaceutical-genhelix
6,000 new jobs in Novo Nordisk create a further 15,000 jobs in Denmark
http://www.pharmanews.eu/novo-nordisk/1451-6000-new-jobs-in-novo-nordisk-create-a-further-15000-jobs-in-denmark
'Tomato pill' improves function of blood vessels in patients with cardiovascular disease
http://www.pharmanews.eu/research-and-development/1450-tomato-pill-improves-function-of-blood-vessels-in-patients-with-cardiovascular-disease
Molecular 'scaffold' could hold key to new dementia treatments
http://www.pharmanews.eu/research-and-development/1447-molecular-scaffold-could-hold-key-to-new-dementia-treatments
Pharmacists develop three new drug candidates against inflammation
http://www.pharmanews.eu/research-and-development/1448-pharmacists-develop-three-new-drug-candidates-against-inflammation
Antibiotic crisis needs united global response, experts say
http://www.pharmanews.eu/research-and-development/1449-antibiotic-crisis-needs-united-global-response-experts-say
With best regards,
Ruslan David
Administrator/Editor
DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany
eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu
PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please feel free to contact us: http://www.worldpharmanews.com/contact-us
BBK Worldwide, a leading clinical trial marketing firm, has unveiled two new mobile apps for patient and site engagement, My Clinical Study Buddy℠ and My Clinical Study Buddy℠ Protocol Pointers Edition. Available for Apple® and Android™ mobile phones and tablets, both apps are available on the App Store℠ and Google Play™ and are being demoed at this week's DIA 2014 50th Annual Meeting at the San Diego Convention Center, San Diego, Calif., June 16-19 at BBK booth #2309.
Read more...
http://www.worldpharmanews.com/development/2806-bbk-worldwide-makes-clinical-engagement-process-easier-with-mobile-apps
Pfizer opens new state-of-the-Art research and development site in Cambridge, Massachusetts
Pfizer Inc. (NYSE:PFE) has announced the opening of a new 280,000 square-foot Research and Development (R&D) hub in Cambridge, Mass. The new Pfizer facilities in Kendall Square bring together 1,000 colleagues from three area locations and position Pfizer in closer proximity to leading academic institutions, hospitals and patient organizations.
Read more...
http://www.worldpharmanews.com/pfizer/2805-pfizer-opens-new-state-of-the-art-research-and-development-site-in-cambridge-massachusetts
Scientists closing in on new obesity drug
Obesity and diabetes are among the fastest growing health problems in the world, and the hunt is in for a pill that can fight the problem. Now a Danish/British team has come up with a smart tool that will speed up the scientific hunting process, and we may be one step closer to a pill against obesity.
Read more...
http://www.worldpharmanews.com/research/2804-scientists-closing-in-on-new-obesity-drug
FDA launches openFDA to provide easy access to valuable FDA public data
The U.S. Food and Drug Administration has launched openFDA, a new initiative designed to make it easier for web developers, researchers, and the public to access large, important public health datasets collected by the agency.
Read more...
http://www.worldpharmanews.com/fda/2803-fda-launches-openfda-to-provide-easy-access-to-valuable-fda-public-data
Viral infections could be inhibited by naturally occurring protein
By boosting a protein that naturally exists in our cells, an international team of researchers led by the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter, has found a potential way to enhance our ability to sense and inhibit viral infections.
Read more...
http://www.worldpharmanews.com/research/2802-viral-infections-could-be-inhibited-by-naturally-occurring-protein
Mindprint implements market-leading automation solution for Ockham Oncology
Mindprint Inc. and Ockham Development, Inc. have implemented an innovative automation software system to help the global CRO manage trials efficiently to ensure a more focused approach to its core oncology mission.
Read more...
http://www.worldpharmanews.com/corporate/2801-mindprint-implements-market-leading-automation-solution-for-ockham-oncology
Researchers uncover common heart drug's link to diabetes
McMaster University researchers may have found a novel way to suppress the devastating side effect of statins, one of the worlds' most widely used drugs to lower cholesterol and prevent heart disease. The research team - led by Jonathan Schertzer, assistant professor of Biochemistry and Biomedical Sciences and Canadian Diabetes Association Scholar - discovered one of the pathways that link statins to diabetes.
Read more...
http://www.worldpharmanews.com/research/2800-researchers-uncover-common-heart-drugs-link-to-diabetes
Resistance to lung cancer targeted therapy can be reversed, study suggests
Up to 40 percent of lung cancer patients do not respond to a targeted therapy designed to block tumor growth - a puzzling clinical setback that researchers have long tried to solve. Now, scientists at Georgetown Lombardi Comprehensive Cancer Center and the National Cancer Institute have discovered why that intrinsic resistance occurs - and they pinpoint a drug they say could potentially reverse it.
Read more...
http://www.worldpharmanews.com/research/2799-resistance-to-lung-cancer-targeted-therapy-can-be-reversed-study-suggests
'Tomato pill' improves function of blood vessels in patients with cardiovascular disease
A daily supplement of an extract found in tomatoes may improve the function of blood vessels in patients with cardiovascular disease, according to new research from the University of Cambridge. The incidence of cardiovascular disease varies worldwide, but is notably reduced in southern Europe, where a 'Mediterranean diet' consisting of a larger consumption of fruit, vegetables and olive oil predominates.
Read more...
http://www.worldpharmanews.com/research/2798-tomato-pill-improves-function-of-blood-vessels-in-patients-with-cardiovascular-disease
PharmaNews.eu / Latest News
Burden of asthma revealed in newly published Mundipharma research
http://www.pharmanews.eu/research-and-development/1453-burden-of-asthma-revealed-in-newly-published-mundipharma-research
mAbxience acquires 100% of biopharmaceutical Genhelix
http://www.pharmanews.eu/research-and-development/1452-mabxience-acquires-100-of-biopharmaceutical-genhelix
6,000 new jobs in Novo Nordisk create a further 15,000 jobs in Denmark
http://www.pharmanews.eu/novo-nordisk/1451-6000-new-jobs-in-novo-nordisk-create-a-further-15000-jobs-in-denmark
'Tomato pill' improves function of blood vessels in patients with cardiovascular disease
http://www.pharmanews.eu/research-and-development/1450-tomato-pill-improves-function-of-blood-vessels-in-patients-with-cardiovascular-disease
Molecular 'scaffold' could hold key to new dementia treatments
http://www.pharmanews.eu/research-and-development/1447-molecular-scaffold-could-hold-key-to-new-dementia-treatments
Pharmacists develop three new drug candidates against inflammation
http://www.pharmanews.eu/research-and-development/1448-pharmacists-develop-three-new-drug-candidates-against-inflammation
Antibiotic crisis needs united global response, experts say
http://www.pharmanews.eu/research-and-development/1449-antibiotic-crisis-needs-united-global-response-experts-say
With best regards,
Ruslan David
Administrator/Editor
DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany
eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu
PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please feel free to contact us: http://www.worldpharmanews.com/contact-us
Reply all
Reply to author
Forward
0 new messages